Skip to content
Search AI Powered

Latest Stories

Health inequalities in England: Major illness rate significantly higher in deprived areas

Health inequalities in England: Major illness rate significantly higher in deprived areas

The Health Foundation report predicts that 80% of the increase in major illness among working-age people will be concentrated in more deprived areas

Health inequalities will persist over the next two decades, with long-term conditions like chronic pain, type 2 diabetes and anxiety and depression likely to increase at a faster rate in the most deprived areas, according to a new report from the Health Foundation.

People in the most deprived areas are anticipated to experience major illnesses 10 years earlier than those in the least deprived areas. They also face a threefold higher risk of dying before the age of 70 years.


Overall, the report projected that the number of working-age adults experiencing a major illness could grow from 3 million in 2019 to 3.7 million in 2040. Notably, 80 per cent of this projected increase is expected to be concentrated in more deprived areas (deciles 1–5).

In 2040, the number of working-age adults living with major illness in the most deprived areas is expected to be more than double the rate in the least deprived areas, with figures projected at 15.2 per cent compared to 6.8 per cent.  This contrasts with 14.6 per cent and 6.3 per cent respectively in 2019.

Led by the Health Foundation's Real Centre in collaboration with the University of Liverpool, the study examined inequalities in major illness among working-age people.

Govt should invest in primary care 

A small group of long-term conditions, including COPD, chronic pain, type 2 diabetes and anxiety and depression, are believed to be contributing most of the observed health inequalities.

Given that these conditions are typically managed by GPs and community services, the report emphasised the importance of investing in primary care and focusing on prevention.

In its previous report, the charity projected that 9.3 million people, around 1 in 5 adults in England, could be living with a major illness by 2040.

The majority of this rise is expected to occur among people aged 70 years and older. The number of this demographic group living with diagnosed a major illness is projected to increase to 5.5 million by 2040 from 3.6 million in 2019.

The report recommended that government action should include “policies at a population level, particularly to address the biggest risk factors that shape health outcomes – smoking, alcohol use, poor diet and physical inactivity – including bolder use of tax and regulation, and a focus on addressing the commercial determinants of health.”

Adding to the growing evidence, the Health Foundation report noted that “tackling health inequality cannot wait until we have economic prosperity; it is one of the key areas of national and local policy focus on which prosperity depends.”

Trusts need more support to tackle health inequalities

In response to this report, NHS Providers has emphasised the need for increased support and funding to assist trusts in addressing health inequalities.

Saffron Cordery, deputy chief executive at NHS Providers said: "More support and funding for public health services is vital to ensure a healthier population. Prevention is better than cure.

"These findings are worrying but sadly not surprising given the cuts to public health and prevention services over the years.

"National support is vitally needed for local councils to meaningfully improve the health and wellbeing of their communities. Without it, demand for already-stretched NHS services will rise even further.”

Furthermore, Cordery underscored the importance of adopting a whole-government approach to prevent ill health, starting with “tackling the root causes of why some people – such as those living in poverty and in deprived areas, as well as ethnic minorities and people with learning disabilities – are more likely to have worse physical and mental health.”

"Trusts are working hard to prevent ill health and reduce health inequalities. Alongside more support for community services and social care, there must be a greater focus on the wider factors that could help people to lead healthier and more productive lives,” she added.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less